Skip to content

HyCON Labs

+1 (631) 210-5235

info@hyconlabs.com

  • Services
    • Product Development
      • Formulation
        • Preformulation Studies
        • Formulation Development
      • Analytical
        • Analytical Method Development
        • Analytical Testing
        • Stability Testing
      • Polymorph Screening
      • IND Enabling Studies
      • GLP Toxicology Studies
      • Therapeutic Area
        • Orphan Disease / Rare Disease
        • Oncology
        • CNS / Neurology
        • Cardiometabolic Diseases
      • Pediatrics
    • Processing Technologies
      • Spray Drying
      • Wurster Fluid Bed Coating
      • Hot Melt Extrusion
      • Micronization & Milling
      • Particle Engineering
    • Clinical Trial Supply
      • Clinical Manufacturing
      • Solutions by Phase
        • Preclinical Manufacturing
        • Phase 1 Clinical Manufacturing
        • Phase 2 Clinical Manufacturing
        • Phase 3 Clinical Manufacturing
      • Comparator Sourcing
      • Direct-to-Patient Services
      • Clinical Returns
      • Clinical Packaging
      • Project & Supply Management
    • Pharmaceutical Manufacturing
      • Commercial Manufacturing
      • over-the-counter-contract-manufacturing
      • Technology Transfers
      • High Potent API (HPAPI)
      • Scheduled Substances
      • Packaging
      • Regulatory Services
  • Dosage Forms
    • Oral Dosage
      • Oral Solid Dosage
      • Tablets
      • Capsules
      • Softgel
      • Oral Films
      • Oral Suspension & Solutions
      • Semi-Solids
      • Powders & Granules
    • Injectables / Parenterals
    • Topical
      • Semi Solids Dosage Forms
      • Transdermal Patches
      • Ophthalmic / Ocular
    • Transdermal
      • Semi Solids Dosage Forms
      • Transdermal Patches
    • Ophthalmic / Ocular
    • Inhalables / Nasal
    • Liquids
  • Formulation Technologies
    • Bioavailability Enhancement
    • Lipid Nanoparticles
      • Nanostructured Lipid Carriers
      • Liposomes
      • Solid Lipid Nanoparticles
      • Self-Emulsifying Drug Delivery Systems
      • Nanoemulsions
    • Lipid-Based Drug Delivery
    • Nanoparticles
      • Polymeric Nanoparticles
      • Nanocrystals
    • Amorphous Solid Dispersions
    • Controlled Release
    • Sustained Release
    • Microencapsulation
    • Multiparticulate
    • Taste Masking
    • Orally Disintegrating Tablets
    • Abuse Deterrent
  • Resources
    • Articles
    • Case Study
    • E-Book
    • Executive Summary
    • Offering Sheet
    • White Paper
  • About
    • Schedule a Meeting
    • Corporate Responsibility
    • Contact Us
Contact Us
hyconlabs-final-logo-3 (1) (1)
  • Services
    • Product Development
      • Formulation
        • Preformulation Studies
        • Formulation Development
      • Analytical
        • Analytical Method Development
        • Analytical Testing
        • Stability Testing
      • Polymorph Screening
      • IND Enabling Studies
      • GLP Toxicology Studies
      • Therapeutic Area
        • Orphan Disease / Rare Disease
        • Oncology
        • CNS / Neurology
        • Cardiometabolic Diseases
      • Pediatrics
    • Processing Technologies
      • Spray Drying
      • Wurster Fluid Bed Coating
      • Hot Melt Extrusion
      • Micronization & Milling
      • Particle Engineering
    • Clinical Trial Supply
      • Clinical Manufacturing
      • Solutions by Phase
        • Preclinical Manufacturing
        • Phase 1 Clinical Manufacturing
        • Phase 2 Clinical Manufacturing
        • Phase 3 Clinical Manufacturing
      • Comparator Sourcing
      • Direct-to-Patient Services
      • Clinical Returns
      • Clinical Packaging
      • Project & Supply Management
    • Pharmaceutical Manufacturing
      • Commercial Manufacturing
      • over-the-counter-contract-manufacturing
      • Technology Transfers
      • High Potent API (HPAPI)
      • Scheduled Substances
      • Packaging
      • Regulatory Services
  • Dosage Forms
    • Oral Dosage
      • Oral Solid Dosage
      • Tablets
      • Capsules
      • Softgel
      • Oral Films
      • Oral Suspension & Solutions
      • Semi-Solids
      • Powders & Granules
    • Injectables / Parenterals
    • Topical
      • Semi Solids Dosage Forms
      • Transdermal Patches
      • Ophthalmic / Ocular
    • Transdermal
      • Semi Solids Dosage Forms
      • Transdermal Patches
    • Ophthalmic / Ocular
    • Inhalables / Nasal
    • Liquids
  • Formulation Technologies
    • Bioavailability Enhancement
    • Lipid Nanoparticles
      • Nanostructured Lipid Carriers
      • Liposomes
      • Solid Lipid Nanoparticles
      • Self-Emulsifying Drug Delivery Systems
      • Nanoemulsions
    • Lipid-Based Drug Delivery
    • Nanoparticles
      • Polymeric Nanoparticles
      • Nanocrystals
    • Amorphous Solid Dispersions
    • Controlled Release
    • Sustained Release
    • Microencapsulation
    • Multiparticulate
    • Taste Masking
    • Orally Disintegrating Tablets
    • Abuse Deterrent
  • Resources
    • Articles
    • Case Study
    • E-Book
    • Executive Summary
    • Offering Sheet
    • White Paper
  • About
    • Schedule a Meeting
    • Corporate Responsibility
    • Contact Us
Contact Us
hyconlabs-final-logo-3 (1) (1)
  • Services
    • Product Development
      • Formulation
        • Preformulation Studies
        • Formulation Development
      • Analytical
        • Analytical Method Development
        • Analytical Testing
        • Stability Testing
      • Polymorph Screening
      • IND Enabling Studies
      • GLP Toxicology Studies
      • Therapeutic Area
        • Orphan Disease / Rare Disease
        • Oncology
        • CNS / Neurology
        • Cardiometabolic Diseases
      • Pediatrics
    • Processing Technologies
      • Spray Drying
      • Wurster Fluid Bed Coating
      • Hot Melt Extrusion
      • Micronization & Milling
      • Particle Engineering
    • Clinical Trial Supply
      • Clinical Manufacturing
      • Solutions by Phase
        • Preclinical Manufacturing
        • Phase 1 Clinical Manufacturing
        • Phase 2 Clinical Manufacturing
        • Phase 3 Clinical Manufacturing
      • Comparator Sourcing
      • Direct-to-Patient Services
      • Clinical Returns
      • Clinical Packaging
      • Project & Supply Management
    • Pharmaceutical Manufacturing
      • Commercial Manufacturing
      • over-the-counter-contract-manufacturing
      • Technology Transfers
      • High Potent API (HPAPI)
      • Scheduled Substances
      • Packaging
      • Regulatory Services
  • Dosage Forms
    • Oral Dosage
      • Oral Solid Dosage
      • Tablets
      • Capsules
      • Softgel
      • Oral Films
      • Oral Suspension & Solutions
      • Semi-Solids
      • Powders & Granules
    • Injectables / Parenterals
    • Topical
      • Semi Solids Dosage Forms
      • Transdermal Patches
      • Ophthalmic / Ocular
    • Transdermal
      • Semi Solids Dosage Forms
      • Transdermal Patches
    • Ophthalmic / Ocular
    • Inhalables / Nasal
    • Liquids
  • Formulation Technologies
    • Bioavailability Enhancement
    • Lipid Nanoparticles
      • Nanostructured Lipid Carriers
      • Liposomes
      • Solid Lipid Nanoparticles
      • Self-Emulsifying Drug Delivery Systems
      • Nanoemulsions
    • Lipid-Based Drug Delivery
    • Nanoparticles
      • Polymeric Nanoparticles
      • Nanocrystals
    • Amorphous Solid Dispersions
    • Controlled Release
    • Sustained Release
    • Microencapsulation
    • Multiparticulate
    • Taste Masking
    • Orally Disintegrating Tablets
    • Abuse Deterrent
  • Resources
    • Articles
    • Case Study
    • E-Book
    • Executive Summary
    • Offering Sheet
    • White Paper
  • About
    • Schedule a Meeting
    • Corporate Responsibility
    • Contact Us
Contact Us
Home » Article » Page 5

Article

Menu
  • Services
    • Product Development
      • Formulation
        • Preformulation Studies
        • Formulation Development
      • Analytical
        • Analytical Method Development
        • Analytical Testing
        • Stability Testing
      • Polymorph Screening
      • IND Enabling Studies
      • GLP Toxicology Studies
      • Therapeutic Area
        • Orphan Disease / Rare Disease
        • Oncology
        • CNS / Neurology
        • Cardiometabolic Diseases
      • Pediatrics
    • Processing Technologies
      • Spray Drying
      • Wurster Fluid Bed Coating
      • Hot Melt Extrusion
      • Micronization & Milling
      • Particle Engineering
    • Clinical Trial Supply
      • Clinical Manufacturing
      • Solutions by Phase
        • Preclinical Manufacturing
        • Phase 1 Clinical Manufacturing
        • Phase 2 Clinical Manufacturing
        • Phase 3 Clinical Manufacturing
      • Comparator Sourcing
      • Direct-to-Patient Services
      • Clinical Returns
      • Clinical Packaging
      • Project & Supply Management
    • Pharmaceutical Manufacturing
      • Commercial Manufacturing
      • over-the-counter-contract-manufacturing
      • Technology Transfers
      • High Potent API (HPAPI)
      • Scheduled Substances
      • Packaging
      • Regulatory Services
  • Dosage Forms
    • Oral Dosage
      • Oral Solid Dosage
      • Tablets
      • Capsules
      • Softgel
      • Oral Films
      • Oral Suspension & Solutions
      • Semi-Solids
      • Powders & Granules
    • Injectables / Parenterals
    • Topical
      • Semi Solids Dosage Forms
      • Transdermal Patches
      • Ophthalmic / Ocular
    • Transdermal
      • Semi Solids Dosage Forms
      • Transdermal Patches
    • Ophthalmic / Ocular
    • Inhalables / Nasal
    • Liquids
  • Formulation Technologies
    • Bioavailability Enhancement
    • Lipid Nanoparticles
      • Nanostructured Lipid Carriers
      • Liposomes
      • Solid Lipid Nanoparticles
      • Self-Emulsifying Drug Delivery Systems
      • Nanoemulsions
    • Lipid-Based Drug Delivery
    • Nanoparticles
      • Polymeric Nanoparticles
      • Nanocrystals
    • Amorphous Solid Dispersions
    • Controlled Release
    • Sustained Release
    • Microencapsulation
    • Multiparticulate
    • Taste Masking
    • Orally Disintegrating Tablets
    • Abuse Deterrent
  • Resources
    • Articles
    • Case Study
    • E-Book
    • Executive Summary
    • Offering Sheet
    • White Paper
  • About
    • Schedule a Meeting
    • Corporate Responsibility
    • Contact Us
  • Image showing a baby having a medicine
    Dosage Form Design

    Optimal Oral Drug Delivery for Pediatrics

    Dosage Form Design

    Addressing the Unique Challenge of Pediatric Medication Dosage Delivery in the Pharmaceutical Industry. Establishing suitable dosage regimens for pediatric patients is an…

    Read More Optimal Oral Drug Delivery for PediatricsContinue

  • Image showing stethoscope and medicines
    Development & Bioavailability | Dosage Form Design | Oral Technology

    How to Accelerate Your Drug Product Development

    Development & Bioavailability, Dosage Form Design, Oral Technology

    DRUG DEVELOPMENT AND FORMULATION IS SCIENCE. DOSE DESIGN TO CREATE SUCCESSFUL TREATMENTS IS ART. Developing successful treatments that meet the needs of…

    Read More How to Accelerate Your Drug Product DevelopmentContinue

  • Image showing a doctor treating a patient
    Manufacturing

    Mapping the Pathway to Designing Successful Treatments

    Manufacturing

    Efficient, comprehensive transitions from early phase (preclinical up to phase 1) to late phase  (phase 2 and beyond) are critical to the…

    Read More Mapping the Pathway to Designing Successful TreatmentsContinue

  • A scientist experimenting in a pharma lab
    Development & Bioavailability

    The Role of Roller Compaction in Dose Design

    Development & Bioavailability

    Introduction:  Roller compaction is a popular dry granulation process with some significant advantages over wet granulation processes. It offers better overall stability…

    Read More The Role of Roller Compaction in Dose DesignContinue

  • Commonly Asked Questions about Elemental Impurities
    Small Molecule Analytical

    Commonly Asked Questions about Elemental Impurities

    Small Molecule Analytical

    If scientific literature indicates that elements are not likely to be present in drug product components, and no additional elements are added…

    Read More Commonly Asked Questions about Elemental ImpuritiesContinue

  • pill on hand
    Small Molecule Analytical

    Precision Formulation via Small Batch Optimization

    Small Molecule Analytical

    It is typical to encounter a restricted number of APIs during the initial stages of drug development. This limitation hinders the swift…

    Read More Precision Formulation via Small Batch OptimizationContinue

  • Scientist researching in Hycon
    Small Molecule Analytical

    Raman Spectroscopy in Product Formulation Analysis: A Deep Dive.

    Small Molecule Analytical

    Comparing the dissolution rates and pellet fine structure of branded Zovirax® with three similar acyclovir generic products marketed across the world, all…

    Read More Raman Spectroscopy in Product Formulation Analysis: A Deep Dive.Continue

  • Image showing patient taking a pill
    Development & Bioavailability

    Customer Requirements for Oral Dose Development

    Development & Bioavailability

    Pharmaceutical developers aim for cost-effective oral medications that work well. This can be challenging, requiring an understanding of client, patient, and provider…

    Read More Customer Requirements for Oral Dose DevelopmentContinue

  • Image shows a mice with medicines around it
    Development & Bioavailability

    Translating Lab Discoveries: Preclinical to First-in-Human Development.

    Development & Bioavailability

    Overview Drug developers have to take into account several factors to position a pre-clinical drug candidate  successfully for first-in-human clinical trials. This executive summary will outline…

    Read More Translating Lab Discoveries: Preclinical to First-in-Human Development.Continue

Page navigation

Previous PagePrevious 1 … 3 4 5
Image of ISO Certified Organization
Logo of Current Good Manufacturing Practice
Made in USA Logo
Seal of the United States Drug Enforcement Administration
FDA Approved Icon
WHO - GMP Logo
Certified Organization Logo

Contact us today to start your project in 1 week!

Call +1 (631) 210-5235 to hit the ground running

Contact Us
HyCON Labs a premier small molecule CDMO, enabling pharmaceutical partners to slash development, and manufacturing costs and bring speed to market.
Youtube Linkedin
Services
  • Product Development
  • Processing Technologies
  • Clinical Trial Supply
  • Drug Product Manufacturing
  • Solutions by Phase
Explore
  • Dosage Forms
  • Formulation Technologies
  • Resources
  • About Us
  • Our Locations
Get In Touch

Phone No.: +1 631-210-5235

E-Mail ID: info@hyconlabs.com

© 2025 HyCON Labs Solutions. All Rights Reserved.